Eliem Therapeutics, Inc (ELYM) Financials
Stock symbol ELYM is outdated, potentially delisted? Maybe it is available on other exchange?
ELYM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 112.7 million | 3.0 million |
| June 30, 2023 | 116.3 million | 3.8 million |
| March 31, 2023 | 122.1 million | 5.2 million |
| Dec. 31, 2022 | 135.0 million | 6.3 million |
ELYM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | 3.5 million | 656000 |
| June 30, 2023 | -8.0 million | 777000 |
| March 31, 2023 | -15.2 million | 10.2 million |
| Dec. 31, 2022 | -8.4 million | 1.9 million |
ELYM Net Income
No data available :(
ELYM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 107.4 million | - | 459000 |
| June 30, 2023 | 102.6 million | - | 585000 |
| March 31, 2023 | 109.4 million | - | 687000 |
| Dec. 31, 2022 | 123.6 million | - | 480000 |
ELYM Shares Outstanding
ELYM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 2.9 million | 2.1 million | - |
| June 30, 2023 | - | 3.7 million | 3.0 million | - |
| March 31, 2023 | - | 5.7 million | 17.7 million | - |
| Dec. 31, 2022 | - | 4.9 million | 4.6 million | - |
ELYM Cost of Revenue
No data available :(
ELYM
Price: $5.11
52 week price:
Earnings Per Share: -2.22 USD
P/E Ratio: -1.85
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3200
Market Capitalization: 342.7 million